About Amorcyte Leadership Investors Technology Clinical Trials Corporate Development News & Events Amorcyte, Inc. is a wholly-owned company of NeoStem, Inc. (NYSE Amex: NBS). Please visit NeoStem's Investors Portal to learn more about investing NeoStem.